Advanced search
Publication Cover
Epigenomics Volume 4, 2012 - Issue 1
Submit an article Journal homepage
300
Views
0
CrossRef citations to date
0
Altmetric
Review

Epigenetic Regulation of miRNA Genes and their Role in Human Melanomas

Ranjan J PereraCorrespondence[email protected]
View further author information
&
Animesh Ray1 Keck Graduate Institute, 535 Watson Drive, Claremont, CA91711, USAView further author information
Pages 81-90 | Published online: 14 Feb 2012

References

  • Clark WH Jr, Elder DE, Guerry DT, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol.15(12) , 1147–1165 (1984).
  • Moan J , DahlbackA, SetlowRB. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem. Photobiol.70(2) , 243–247 (1999).
  • Runkle GP , ZaloznikAJ. Malignant melanoma. Am. Fam. Physician49(1) , 91–98, 102–104 (1994).
  • Kuchelmeister C , Schaumburg-LeverG, GarbeC. Acral cutaneous melanoma in caucasians. clinical features, histopathology and prognosis in 112 patients. Br. J. Dermatol.143(2) , 275–280 (2000).
  • Situm M , BolancaZ, BuljanM. Lentigo maligna melanoma--the review. Coll. Antropol.34(Suppl. 2) , 299–301 (2010).
  • Adler MJ , WhiteCR Jr. Amelanotic malignant melanoma. Semin. Cutan. Med. Surg.16(2) , 122–130 (1997).
  • Forman SB , FerringerTC, PeckhamSJ et al. Is superficial spreading melanoma still the most common form of malignant melanoma? J. Am. Acad. Dermatol. 58(6) , 1013–1020 (2008).
  • Curtin JA , FridlyandJ, KageshitaT et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353(20) , 2135–2147 (2005).
  • Ren S , LiuS, HowellP Jr et al. The impact of genomics in understanding human melanoma progression and metastasis. Cancer Control15(3) , 202–215 (2008).
  • Carr KM , BittnerM, TrentJM. Gene-expression profiling in human cutaneous melanoma. Oncogene22(20) , 3076–3080 (2003).
  • Houghton AN , PolskyD. Focus on melanoma. Cancer Cell2(4) , 275–278 (2002).
  • Hoek K , RimmDL, WilliamsKR et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 64(15) , 5270–5282 (2004).
  • Alonso SR , TraceyL, OrtizP et al. A high-throughput study in melanoma identifies epithelial–mesenchymal transition as a major determinant of metastasis. Cancer Res. 67(7) , 3450–3460 (2007).
  • Kudo-Saito C , ShirakoH, TakeuchiT, KawakamiY. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell15(3) , 195–206 (2009).
  • Bennett DC . How to make a melanoma. what do we know of the primary clonal events? Pigment Cell Melanoma Res.21(1) , 27–38 (2008).
  • Johnson JM , EdwardsS, ShoemakerD, SchadtEE. Dark matter in the genome. evidence of widespread transcription detected by microarray tiling experiments. Trends Genet.21(2) , 93–102 (2005).
  • Van Bakel H , NislowC, BlencoweBJ, HughesTR. Most ‘dark matter‘ transcripts are associated with known genes. PLoS Biol.8(5) , e1000371 (2010).
  • Clark MB , AmaralPP, SchlesingerFJ et al. The reality of pervasive transcription. PLoS Biol. 9(7) , e1000625; discussion e1001102 (2011).
  • Calin GA , CroceCM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene25(46) , 6202–6210 (2006).
  • Chen CZ . MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med.353(17) , 1768–1771 (2005).
  • Dalmay T , EdwardsDR. MicroRNAs and the hallmarks of cancer. Oncogene25(46) , 6170–6175 (2006).
  • Esquela-Kerscher A , SlackFJ. Oncomirs – microRNAs with a role in cancer. Nat. Rev. Cancer6(4) , 259–269 (2006).
  • Hwang HW , MendellJT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer94(6) , 776–780 (2006).
  • Lee YS , DuttaA. MicroRNAs. small but potent oncogenes or tumor suppressors. Curr. Opin. Investig. Drugs7(6) , 560–564 (2006).
  • Slack FJ , WeidhaasJB. MicroRNAs as a potential magic bullet in cancer. Future Oncol.2(1) , 73–82 (2006).
  • Volinia S , CalinGA, LiuCG et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103(7) , 2257–2261 (2006).
  • Zhang B , PanX, CobbGP, AndersonTA. microRNAs as oncogenes and tumor suppressors. Dev. Biol.302(1) , 1–12 (2007).
  • Saito Y , JonesPA. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle5(19) , 2220–2222 (2006).
  • Voorhoeve PM , Le Sage C, Schrier M et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell124(6) , 1169–1181 (2006).
  • Ruvkun G . Clarifications on miRNA and cancer. Science311(5757) , 36–37 (2006).
  • Hammond SM . MicroRNAs as oncogenes. Curr. Opin. Genet. Dev.16(1) , 4–9 (2006).
  • Tam W , DahlbergJE. miR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer45(2) , 211–212 (2006).
  • Hede K . Studies define role of microRNA in cancer. J. Natl Cancer Inst.97(15) , 1114–1115 (2005).
  • Eder M , ScherrM. MicroRNA and lung cancer. N. Engl. J. Med.352(23) , 2446–2448 (2005).
  • Mcmanus MT . MicroRNAs and cancer. Semin Cancer Biol13(4) , 253–258 (2003).
  • Calin GA , CimminoA, FabbriM et al. MiR-15a and miR-16–11 cluster functions in human leukemia. Proc. Natl Acad. Sci. USA 105(13) , 5166–5171 (2008).
  • Xia L , ZhangD, DuR et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123(2) , 372–379 (2008).
  • Mazar J , DeyoungK, KhaitanD et al. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS ONE 5(11) , e13779 (2010).
  • Bird A . Perceptions of epigenetics. Nature447(7143) , 396–398 (2007).
  • Vinod Saladi S , MaratheH, De La Serna IL. SWItching on the transcriptional circuitry in melanoma. Epigenetics5(6) , 469–475 (2010).
  • Brait M , SidranskyD. Cancer epigenetics. above and beyond. Toxicol. Mech. Methods21(4) , 275–288 (2011).
  • Portela A , EstellerM. Epigenetic modifications and human disease. Nat. Biotechnol.28(10) , 1057–1068 (2010).
  • Grewal SI , MoazedD. Heterochromatin and epigenetic control of gene expression. Science301(5634) , 798–802 (2003).
  • Robertson KD . DNA methylation and human disease. Nat. Rev. Genet.6(8) , 597–610 (2005).
  • Okano M , BellDW, HaberDA, LiE. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell99(3) , 247–257 (1999).
  • Bestor T , LaudanoA, MattalianoR, IngramV. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol.203(4) , 971–983 (1988).
  • Li E , BestorTH, JaenischR. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell69(6) , 915–926 (1992).
  • Gonzalgo ML , BenderCM, YouEH et al. Low frequency of p16/CDKN2A methylation in sporadic melanoma. comparative approaches for methylation analysis of primary tumors. Cancer Res. 57(23) , 5336–5347 (1997).
  • Worm J , BartkovaJ, KirkinAF et al. Aberrant p27Kip1 promoter methylation in malignant melanoma. Oncogene 19(44) , 5111–5115 (2000).
  • Worm J , ChristensenC, GronbaekK, TulchinskyE, GuldbergP. Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene23(30) , 5215–5226 (2004).
  • Hoon DS , SpugnardiM, KuoC, HuangSK, MortonDL, TabackB. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene23(22) , 4014–4022 (2004).
  • Guan X , SagaraJ, YokoyamaT et al. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma. Int. J. Cancer 107(2) , 202–208 (2003).
  • Gaur A , JewellDA, LiangY et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67(6) , 2456–2468 (2007).
  • Fabbri M , GarzonR, CimminoA et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104(40) , 15805–15810 (2007).
  • Fazi F , RacanicchiS, ZardoG et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12(5) , 457–466 (2007).
  • Grady WM , ParkinRK, MitchellPS et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27(27) , 3880–3888 (2008).
  • Lehmann U , HasemeierB, ChristgenM et al. Epigenetic inactivation of microRNA gene hsa-mir-9–1 in human breast cancer. J. Pathol. 214(1) , 17–24 (2008).
  • Rothhammer T , BosserhoffAK. Epigenetic events in malignant melanoma. Pigment Cell Res.20(2) , 92–111 (2007).
  • Maat W , Van Der Velden PA, Out-Luiting C et al. Epigenetic inactivation of RASSF1a in uveal melanoma. Invest. Ophthalmol. Vis. Sci.48(2) , 486–490 (2007).
  • Jeffery L , NakielnyS. Components of the DNA methylation system of chromatin control are RNA-binding proteins. J. Biol. Chem.279(47) , 49479–49487 (2004).
  • Bernstein E , AllisCD. RNA meets chromatin. Genes Dev.19(14) , 1635–1655 (2005).
  • Robins H , LiY, PadgettRW. Incorporating structure to predict microRNA targets. Proc. Natl Acad. Sci. USA102(11) , 4006–4009 (2005).
  • Kim VN , NamJW. Genomics of microRNA. Trends Genet.22(3) , 165–173 (2006).
  • Hill AE , HongJS, WenH et al. Micro-RNA-like effects of complete intronic sequences. Front Biosci. 11 , 1998–2006 (2006).
  • Ying SY , LinSL. Intronic microRNAs. Biochem. Biophys. Res. Commun.326(3) , 515–520 (2005).
  • Ying SY , LinSL. Intron-derived microRNAs – fine tuning of gene functions. Gene342(1) , 25–28 (2004).
  • Ying SY , LinSL. Current perspectives in intronic micro RNAs (miRNAs). J. Biomed. Sci.13(1) , 5–15 (2006).
  • Stolc V , SamantaMP, TongprasitW et al. Identification of transcribed sequences in Arabidopsis thaliana by using high-resolution genome tiling arrays. Proc. Natl Acad. Sci. USA 102(12) , 4453–4458 (2005).
  • Robins H , PressWH. Human microRNAs target a functionally distinct population of genes with AT-rich 3´ UTRs. Proc. Natl Acad. Sci. USA102(43) , 15557–15562 (2005).
  • Xie X , LuJ, KulbokasEJ et al. Systematic discovery of regulatory motifs in human promoters and 3´ UTRs by comparison of several mammals. Nature 434(7031) , 338–345 (2005).
  • Jing Q , HuangS, GuthS et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120(5) , 623–634 (2005).
  • Ambros V , LeeRC, LavanwayA, WilliamsPT, JewellD. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr. Biol.13(10) , 807–818 (2003).
  • Tijsterman M , PlasterkRH. Dicers at RISC; the mechanism of RNAi. Cell117(1) , 1–3 (2004).
  • Yang WJ , YangDD, NaS, SanduskyGE, ZhangQ, ZhaoG. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem.280(10) , 9330–9335 (2005).
  • Lee YS , NakaharaK, PhamJW et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117(1) , 69–81 (2004).
  • Suzuki H , TakatsukaS, AkashiH et al. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer. Cancer Res. 71(17) , 5646–5658 (2011).
  • Braconi C , KogureT, ValeriN et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30(47) , 4750–4756 (2011)
  • Cao Q , ManiRS, AteeqB et al. Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell 20(2) , 187–199 (2011).
  • So AY , JungJW, LeeS, KimHS, KangKS. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PLoS ONE6(5) , e19503 (2011).
  • Mazar J , DeblasioD, GovindarajanSS, ZhangS, PereraRJ. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. FEBS Lett.585(15) , 2467–2476 (2011).
  • Khaitan D , DingerME, MazarJ et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 71(11) , 3852–3862 (2011).
  • Lujambio A , CalinGA, VillanuevaA et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 105(36) , 13556–13561 (2008).
  • De Souza Rocha Simonini P , BreilingA, GuptaN et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 70(22) , 9175–9184 (2010).
  • Ding L , XuY, ZhangW et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 20(7) , 784–793 (2010).
  • Tsukamoto Y , NakadaC, NoguchiT et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14–13–3zeta. Cancer Res. 70(6) , 2339–2349 (2010).
  • Dhawan P , SinghAB, EllisDL, RichmondA. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res.62(24) , 7335–7342 (2002).
  • Ura K , ArakiM, SaekiH et al. ATP-dependent chromatin remodeling facilitates nucleotide excision repair of UV-induced DNA lesions in synthetic dinucleosomes. EMBO J. 20(8) , 2004–2014 (2001).
  • Martini E , RocheDM, MarheinekeK, VerreaultA, AlmouzniG. Recruitment of phosphorylated chromatin assembly factor 1 to chromatin after UV irradiation of human cells. J. Cell Biol.143(3) , 563–575 (1998).
  • Ferraiuolo MA , LeeCS, LerLW et al. A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay. Proc. Natl Acad. Sci. USA 101(12) , 4118–4123 (2004).
  • Lejeune F , RanganathanAC, MaquatLE. eIF4G is required for the pioneer round of translation in mammalian cells. Nat. Struct. Mol. Biol.11(10) , 992–1000 (2004).
  • Brumbaugh KM , OtternessDM, GeisenC et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell 14(5) , 585–598 (2004).
  • Chiu SY , LejeuneF, RanganathanAC, MaquatLE. The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex. Genes Dev.18(7) , 745–754 (2004).
  • Maquat LE . Nonsense-mediated mRNA decay. splicing, translation and mRNP dynamics. Nat. Rev. Mol. Cell Biol.5(2) , 89–99 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.